Results 181 to 190 of about 1,360,024 (265)

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

Molecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens, Anouk Mentink, Tom Niessink, Frank Coumans, Leonie Mekenkamp, Ruchi Bansal, Jeroen Hiltermann   +6 more
wiley   +1 more source

Global Burden of Disease disability weights for the US National Electronic Injury Surveillance System - All Injury Program. [PDF]

Inj Prev
Moberg ME, Steinmetz JD, Ong KL, Lenox H, Miller TR, Peterson C.   +5 more
europepmc   +1 more source

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

Molecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder, Klaas de Lint, Hồ Mỹ Phúc Võ, Mariana M. Góis, Rosalie A. Kampen, Marta San Martin Alonso, Ilse Nootenboom, Veronica Garzero, Tiemen J. Wendel, Rob M. F. Wolthuis, Sylvie M. Noordermeer   +10 more
wiley   +1 more source

Quantifying the fatal and non-fatal burden of disease associated with child growth failure, 2000-2023: a systematic analysis from the Global Burden of Disease Study 2023. [PDF]

Lancet Child Adolesc Health
GBD 2023 Child Growth Failure Collaborators.
europepmc   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

Molecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi, Stavros Makrodimitris, Sandra van Wilpe, Iris te Paske, Vanja de Weerd, Corine M. Beaufort, Hans M. Westgeest, Jens Voortman, Maureen J. B. Aarts, Maud Rijnders, Astrid A. M. van der Veldt, Ronald de Wit, Niven Mehra, Saskia M. Wilting, Debbie G. J. Robbrecht   +14 more
wiley   +1 more source

Modifiable Risk Factors for Atrial Fibrillation/Flutter in the Association of Southeast Asian Nations: Global Burden of Disease 2021. [PDF]

JACC Adv
Baig MMA, Umar M, Manzoor I, Noor R, Tariq B, Usman FM, Bano S, Parkash C, Biswas S, Nabi R, Asim O, Awais AR, Mansoor M, Baig F, Ul Haq MA, Moiz MA, Zahoor RMW, Chew NW, Sattar Y.   +18 more
europepmc   +1 more source

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

Molecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu, Nicolas J. Niklaus, Anna M. Schläfli, Igor Tokarchuk, Magali Humbert, Federico La Manna, Bich Vu, David Maul, Ramin Radpour, Marianna Kruithof‐de Julio, Inti Zlobec, Jörn Dengjel, Bruce E. Torbett, Mario P. Tschan   +13 more
wiley   +1 more source

Lay descriptions of painful temporomandibular disorders-an international consensus proposal for Global Burden of Disease estimates. [PDF]

BMC Med
Lövgren A, Liv P, Allison JR, Baad-Hansen L, Beecroft EV, Bergman S, Bijelic T, Bucci R, Böthun A, Christidis N, Colonna A, Draghici R, Drangsholt M, Durham J, Ernberg M, Giannakopoulos NN, Gonçalves DAG, Groenke B, Jusakos M, Lobbezoo F, Lua ESP, Lunecke G, Malysa A, Manfredini D, Marpaung C, Michelotti A, Moana-Filho E, Moreno B, Nilsson E, Nixdorf DR, Nykänen L, Oyarzo JF, Peck CC, Penlington C, Restrepo C, Rongo R, Schierz O, Stanisic N, Visscher CM, Wieckiewicz M, Xiong X, Xu YY, Yanez C, Häggman-Henrikson B, Svensson P.   +44 more
europepmc   +1 more source

Tumor B‐cell infiltration in platinum‐treated advanced muscle‐invasive urothelial carcinoma

Molecular Oncology, EarlyView.
Bladder tumors with higher pretreatment memory B‐cell infiltration were linked to longer survival after cisplatin chemotherapy, but not carboplatin. These tumors also showed more organized immune structures (tertiary lymphoid structures) and a shared pro‐inflammatory B‐cell‐rich community, suggesting that memory B cells may help identify patients most ...
Konrad Stawiski, Júlia Perera‐Bel, Alejo Rodriguez‐Vida, Nuria Juanpere, Jihyun Lee, Daniel E. Michaud, Jennifer L. Guerriero, Kent W. Mouw, Aristotelis Bamias, Filipe L. F. Carvalho, Joaquim Bellmunt   +10 more
wiley   +1 more source

Burden and temporal trends of female-specific cancers in China: A systematic analysis of the 2023 global burden of disease study. [PDF]

PLoS One
Chen S, Yang X, Jiang S, Lin Y, Huang L, Chen H, Zheng J, Xie Y, Kuang Z.   +8 more
europepmc   +1 more source